Geode Capital Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.06M | Buy |
|
|||||
|
2025
Q2 | $2.86M | Sell |
|
|||||
|
2025
Q1 | $2.12M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Buy |
|
|||||
|
2024
Q3 | $2.93M | Buy |
|
|||||
|
2024
Q2 | $2.53M | Buy |
|
|||||
|
2024
Q1 | $2.72M | Buy |
|
|||||
|
2023
Q4 | $3.37M | Buy |
|
|||||
|
2023
Q3 | $3.64M | Buy |
|
|||||
|
2023
Q2 | $4.54M | Buy |
|
|||||
|
2023
Q1 | $1.55M | Buy |
|
|||||
|
2022
Q4 | $694K | Buy |
|
|||||
|
2022
Q3 | $555K | Buy |
|
|||||
|
2022
Q2 | $378K | Buy |
|
|||||
|
2022
Q1 | $393K | Sell |
|
|||||
|
2021
Q4 | $357K | Sell |
|
|||||
|
2021
Q3 | $473K | Buy |
|
|||||
|
2021
Q2 | $406K | Sell |
|
|||||
|
2021
Q1 | $652K | Buy |
|
|||||
|
2020
Q4 | $484K | Buy |
|
|||||
|
2020
Q3 | $635K | Buy |
|
|||||
|
2020
Q2 | $553K | Buy |
|
|||||
|
2020
Q1 | $229K | Hold |
|
|||||
|
2019
Q4 | $175K | Sell |
|
|||||
|
2019
Q3 | $193K | Hold |
|
|||||
|
2019
Q2 | $104K | Sell |
|
|||||
|
2019
Q1 | $165K | Buy |
|
|||||
|
2018
Q4 | $195K | Buy |
|
|||||
|
2018
Q3 | $295K | Buy |
|
|||||
|
2018
Q2 | $264K | Buy |
|
|||||
|
2018
Q1 | $501K | Buy |
|